Frequently Asked Questions
The market is segmented based on Segmentation, By Type (Safety Biomarkers, Efficacy Biomarkers, Validation Biomarker), Product (Consumables, Services, Software, Growth Hormone Therapy), Mechanism (Genetic, Epigenetic, Proteomic, Lipidomic, and Other Mechanisms), Application (Diagnostics Development, Drug Discovery and Development, Personalized Medicine, Disease Risk Assessment, Others), Disease Indication (Cancer, Cardiovascular Disorders, Neurological Disorders, Immunological Disorders, Others) – Industry Trends and Forecast to 2031.
.
The Europe Biomarkers Market size was valued at USD 16.00 USD Billion in 2023.
The Europe Biomarkers Market is projected to grow at a CAGR of 13.6% during the forecast period of 2024 to 2031.
The major players operating in the market include F. Hoffmann-La Roche , Thermo Fisher Scientific , Abbott, QIAGEN, PerkinElmer , Merck KGaA, Bio-Rad Laboratories , Enzo Biochem , Charles River Laboratories International , Eurofins Scientific, Agilent Technologies , Bruker, Siemens, Epigenomics AG, General Electric .
The market report covers data from the Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe.